Dielectric Spectroscopy for Endothelial Cell Permeability Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a reliable and cost-effective way to measure and evaluate the paracellular permeability of endothelial cell layers, particularly in response to external stimuli such as drugs, which is crucial for understanding and treating diseases associated with abnormal permeability.
Innovation Solution
A method involving dielectric spectroscopy to measure frequency-dependent capacitance of endothelial cell layers at frequencies between 100 Hz to 5 kHz, allowing for the screening of drugs that affect paracellular permeability by stabilizing the cell layer between electrodes and comparing capacitance values before and after drug contact.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional methods are used to measure endothelial cell layer permeability, then measurement capability is limited, but the complexity and cost of the system increases
Solution Approach 1:
The patent replaces complex mechanical or optical measurement systems with an electrical measurement system based on dielectric spectroscopy. By measuring the dielectric properties (capacitance, conductance) of the endothelial cell layer using electrical fields, the system achieves accurate permeability measurement without requiring complex mechanical or optical apparatus. This substitution of measurement modality resolves the contradiction between measurement precision and device complexity.
2Measurement precision
If advanced measurement techniques are implemented to evaluate drug effects on permeability, then measurement accuracy improves, but the cost and operational complexity increases
Solution Approach 1:
The endothelial cell layer itself serves as the measurement sensor in this system. The dielectric properties of the cell layer directly reflect its permeability state, eliminating the need for separate indicator substances or complex assay procedures. When drugs are applied, the changes in dielectric properties provide direct, real-time information about permeability changes. This self-measuring capability maintains high evaluation accuracy while significantly simplifying operational procedures and reducing costs.
3Productivity
If conventional permeability assessment methods are used, then procedural complexity increases, but the ability to screen drugs efficiently decreases
Solution Approach 1:
The dielectric spectroscopy system enables continuous, real-time monitoring of endothelial cell layer permeability throughout the drug screening process. Unlike conventional methods that require discrete sampling and analysis steps, this system continuously measures dielectric properties, providing an uninterrupted data stream that directly reflects permeability changes. This continuous measurement capability dramatically increases drug screening productivity while keeping the measurement procedure simple and automated.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the simple, reproducible, and cost-effective screening of drugs that increase or decrease paracellular permeability, aiding in the treatment of endothelial cell layer abnormalities and providing insights into disease mechanisms.
Implementation Method 1
dielectric spectroscopy, which is to apply an alternating current (AC) electric field to cells to thereby measure specific dielectric responses according to interfacial polarization patterns
Implementation Method 2
measure specific dielectric responses according to interfacial polarization patterns
Implementation Method 3
measuring capacitance of an endothelial cell layer contacting a drug at a frequency region of 100 Hz to 5 kHz to screen a drug affecting paracellular permeability
Data Source
AI summary
Provided is a method for screening drugs, more particularly, a method for screening drugs by measuring capacitance of an endothelial cell layer at a frequency region of 100 Hz to 5 kHz to screen a drug affecting paracellular permeability of the endothelial cell layer or a drug penetrating through a paracellular path.